APA citiranje

Vilsbøll, T., Vora, J., Jarlov, H., Kvist, K., & Blonde, L. (2016). Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone. Clin Drug Investig.

Citação norma Chicago

Vilsbøll, Tina, Jiten Vora, Henrik Jarlov, Kajsa Kvist, and Lawrence Blonde. "Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira Than Either Insulin Degludec or Liraglutide Given Alone." Clin Drug Investig 2016.

MLA citiranje

Vilsbøll, Tina, et al. "Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira Than Either Insulin Degludec or Liraglutide Given Alone." Clin Drug Investig 2016.